Mednax Market Capitalization from 2010 to 2025

MD Stock  USD 14.74  0.11  0.75%   
Mednax's Market Cap is decreasing over the years with slightly volatile fluctuation. Market Cap is expected to dwindle to about 853.6 M.
Check Mednax financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mednax's main balance sheet or income statement drivers, such as Depreciation And Amortization of 32.7 M, Interest Expense of 25.1 M or Total Revenue of 1.5 B, as well as many indicators such as Price To Sales Ratio of 0.52, Dividend Yield of 0.0 or PTB Ratio of 1.36. Mednax financial statements analysis is a perfect complement when working with Mednax Valuation or Volatility modules.
  
Check out the analysis of Mednax Correlation against competitors.

Latest Mednax's Market Capitalization Growth Pattern

Below is the plot of the Market Cap of Mednax Inc over the last few years. It is Mednax's Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Mednax's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 1.27 B10 Years Trend
Slightly volatile
   Market Cap   
       Timeline  

Mednax Market Capitalization Regression Statistics

Arithmetic Mean1,592,917,618
Geometric Mean1,184,036,871
Coefficient Of Variation93.76
Mean Deviation1,193,639,801
Median781,367,614
Standard Deviation1,493,485,126
Sample Variance2230497.8T
Range4.6B
R-Value(0.67)
Mean Square Error1308279.9T
R-Squared0.45
Significance0
Slope(211,030,726)
Total Sum of Squares33457467.3T

Mednax Market Capitalization History

2025853.6 M
2024898.6 M
2014781.4 M
20135.4 B
2012B
20113.5 B
20103.1 B

About Mednax Financial Statements

Mednax stakeholders use historical fundamental indicators, such as Mednax's Market Capitalization, to determine how well the company is positioned to perform in the future. Although Mednax investors may analyze each financial statement separately, they are all interrelated. For example, changes in Mednax's assets and liabilities are reflected in the revenues and expenses on Mednax's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Mednax Inc. Please read more on our technical analysis and fundamental analysis pages.
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida. Pediatrix Medical operates under Medical Care Facilities classification in the United States and is traded on New York Stock Exchange. It employs 5000 people.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out the analysis of Mednax Correlation against competitors.
You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mednax. If investors know Mednax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mednax listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.11)
Earnings Share
(1.19)
Revenue Per Share
24.156
Quarterly Revenue Growth
0.012
Return On Assets
0.0525
The market value of Mednax Inc is measured differently than its book value, which is the value of Mednax that is recorded on the company's balance sheet. Investors also form their own opinion of Mednax's value that differs from its market value or its book value, called intrinsic value, which is Mednax's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mednax's market value can be influenced by many factors that don't directly affect Mednax's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mednax's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mednax is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mednax's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.